Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Correction to Remarkable Brain Penetration of Cyclopentadienyl M(CO)3+ (M = 99mTc, Re) Derivatives of Benzothiazole and Benzimidazole Paves the Way for Their Application as Diagnostic, with Single-Photon-Emission Computed Tomography (SPECT), and Therapeutic Agents for Alzheimer's Disease.

Sagnou M, Mavroidi B, Shegani A, Paravatou-Petsotas M, Raptopoulou C, Psycharis V, Pirmettis I, Papadopoulos MS, Pelecanou M.

J Med Chem. 2019 Apr 25;62(8):4232. doi: 10.1021/acs.jmedchem.9b00529. Epub 2019 Apr 5. No abstract available.

PMID:
30951301
2.

Remarkable Brain Penetration of Cyclopentadienyl M(CO)3+ (M = 99mTc, Re) Derivatives of Benzothiazole and Benzimidazole Paves the Way for Their Application as Diagnostic, with Single-Photon-Emission Computed Tomography (SPECT), and Therapeutic Agents for Alzheimer's Disease.

Sagnou M, Mavroidi B, Shegani A, Paravatou-Petsotas M, Raptopoulou C, Psycharis V, Pirmettis I, Papadopoulos MS, Pelecanou M.

J Med Chem. 2019 Mar 14;62(5):2638-2650. doi: 10.1021/acs.jmedchem.8b01949. Epub 2019 Feb 28. Erratum in: J Med Chem. 2019 Apr 25;62(8):4232.

PMID:
30768272
3.

A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis.

Tsoukalas C, Psimadas D, Kastis GA, Koutoulidis V, Harris AL, Paravatou-Petsotas M, Karageorgou M, Furenlid LR, Moulopoulos LA, Stamopoulos D, Bouziotis P.

Front Chem. 2018 Jun 20;6:224. doi: 10.3389/fchem.2018.00224. eCollection 2018.

4.

Tumor Targeting via Sialic Acid: [68Ga]DOTA-en-pba as a New Tool for Molecular Imaging of Cancer with PET.

Tsoukalas C, Geninatti-Crich S, Gaitanis A, Tsotakos T, Paravatou-Petsotas M, Aime S, Jiménez-Juárez R, Anagnostopoulos CD, Djanashvili K, Bouziotis P.

Mol Imaging Biol. 2018 Oct;20(5):798-807. doi: 10.1007/s11307-018-1176-0.

PMID:
29464496
5.

A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity.

Panagiotaki KN, Sideratou Z, Vlahopoulos SA, Paravatou-Petsotas M, Zachariadis M, Khoury N, Zoumpourlis V, Tsiourvas D.

Pharmaceuticals (Basel). 2017 Nov 21;10(4). pii: E91. doi: 10.3390/ph10040091.

6.

68Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy.

Bouziotis P, Stellas D, Thomas E, Truillet C, Tsoukalas C, Lux F, Tsotakos T, Xanthopoulos S, Paravatou-Petsotas M, Gaitanis A, Moulopoulos LA, Koutoulidis V, Anagnostopoulos CD, Tillement O.

Nanomedicine (Lond). 2017 Jul;12(13):1561-1574. doi: 10.2217/nnm-2017-0032. Epub 2017 Jun 16.

7.

Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging.

Tsoukalas C, Laurent G, Jiménez Sánchez G, Tsotakos T, Bazzi R, Stellas D, Anagnostopoulos C, Moulopoulos L, Koutoulidis V, Paravatou-Petsotas M, Xanthopoulos S, Roux S, Bouziotis P.

EJNMMI Phys. 2015 Dec;2(Suppl 1):A89. doi: 10.1186/2197-7364-2-S1-A89. No abstract available.

8.

New labeled derivatives of the neuroprotective peptide colivelin: synthesis, characterization, and first in vitro and in vivo applications.

Kostomoiri M, Zikos C, Benaki D, Triantis C, Sagnou M, Paravatou-Petsotas M, Papadaki A, Boleti H, Papadopoulos M, Pirmettis I, Pelecanou M, Livaniou E.

Arch Biochem Biophys. 2015 Feb 1;567:83-93. doi: 10.1016/j.abb.2014.12.027. Epub 2015 Jan 6.

PMID:
25575783
9.

Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.

Tsiapa I, Loudos G, Fragogeorgi EA, Bouziotis P, Psimadas D, Xanthopoulos S, Paravatou-Petsotas M, Palamaris L, Varvarigou AD, Karnabatidis D, Kagadis GC.

Cancer Biother Radiopharm. 2014 Dec;29(10):444-50. doi: 10.1089/cbr.2014.1672.

10.

(99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment.

Tsiapa I, Efthimiadou EK, Fragogeorgi E, Loudos G, Varvarigou AD, Bouziotis P, Kordas GC, Mihailidis D, Nikiforidis GC, Xanthopoulos S, Psimadas D, Paravatou-Petsotas M, Palamaris L, Hazle JD, Kagadis GC.

J Colloid Interface Sci. 2014 Nov 1;433:163-175. doi: 10.1016/j.jcis.2014.07.032. Epub 2014 Aug 1.

PMID:
25128864
11.

Re(I) tricarbonyl complex of 1,10-phenanthroline-5,6-dione: DNA binding, cytotoxicity, anti-inflammatory and anti-coagulant effects towards platelet activating factor.

Kaplanis M, Stamatakis G, Papakonstantinou VD, Paravatou-Petsotas M, Demopoulos CA, Mitsopoulou CA.

J Inorg Biochem. 2014 Jun;135:1-9. doi: 10.1016/j.jinorgbio.2014.02.003. Epub 2014 Feb 17.

PMID:
24632342
12.

Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the (99m)Tc(CO)3(+) core.

Bouziotis P, Gourni E, Patsis G, Psimadas D, Zikos C, Fani M, Xanthopoulos S, Loudos G, Paravatou-Petsotas M, Livaniou E, Varvarigou AD, Pirmettis I, Papadopoulos M.

Bioorg Med Chem. 2013 Nov 1;21(21):6699-707. doi: 10.1016/j.bmc.2013.08.010. Epub 2013 Aug 12.

PMID:
24035515
13.

Structural modifications of ⁹⁹mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting.

Liolios CC, Fragogeorgi EA, Zikos C, Loudos G, Xanthopoulos S, Bouziotis P, Paravatou-Petsotas M, Livaniou E, Varvarigou AD, Sivolapenko GB.

Int J Pharm. 2012 Jul 1;430(1-2):1-17. doi: 10.1016/j.ijpharm.2012.02.049. Epub 2012 Mar 10.

PMID:
22459664
14.

Cholesteryl-functionalized ADNF-9 peptide: enhanced membrane transport through mouse neuroblastoma Neuro-2a cells.

Katsari E, Zikos C, Tziveleka LA, Paravatou-Petsotas M, Paleos CM.

Chem Biol Drug Des. 2012 Jul;80(1):148-54. doi: 10.1111/j.1747-0285.2012.01381.x. Epub 2012 Apr 27.

PMID:
22416980
15.

Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.

Tzanopoulou S, Sagnou M, Paravatou-Petsotas M, Gourni E, Loudos G, Xanthopoulos S, Lafkas D, Kiaris H, Varvarigou A, Pirmettis IC, Papadopoulos M, Pelecanou M.

J Med Chem. 2010 Jun 24;53(12):4633-41. doi: 10.1021/jm1001293.

PMID:
20518489
16.

Solid-phase synthesis of a biotin derivative and its application to the development of anti-biotin antibodies.

Papasarantos I, Klimentzou P, Koutrafouri V, Anagnostouli M, Zikos C, Paravatou-Petsotas M, Livaniou E.

Appl Biochem Biotechnol. 2010 Sep;162(1):221-32. doi: 10.1007/s12010-009-8870-y. Epub 2009 Dec 1.

PMID:
19950001
17.

In vitro binding and in vivo biodistribution studies of the neuroprotective peptide humanin using [125I]humanin derivatives.

Evangelou A, Zikos C, Benaki D, Pelecanou M, Bouziotis P, Papadopoulos M, Borovickova L, Vesela I, Elbert T, Kunesová G, Pirmettis I, Paravatou-Petsotas M, Slaninová J, Livaniou E.

Peptides. 2009 Dec;30(12):2409-17. doi: 10.1016/j.peptides.2009.07.028. Epub 2009 Aug 8.

PMID:
19666070
18.

Structural assessment and biological evaluation of two N3S bombesin derivatives.

Gourni E, Bouziotis P, Benaki D, Loudos G, Xanthopoulos S, Paravatou-Petsotas M, Mavri-Vavagianni M, Pelecanou M, Archimandritis SC, Varvarigou AD.

J Med Chem. 2009 Jul 23;52(14):4234-46. doi: 10.1021/jm900360d.

PMID:
19522464
19.

Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging.

Bourkoula A, Paravatou-Petsotas M, Papadopoulos A, Santos I, Pietzsch HJ, Livaniou E, Pelecanou M, Papadopoulos M, Pirmettis I.

Eur J Med Chem. 2009 Oct;44(10):4021-7. doi: 10.1016/j.ejmech.2009.04.033. Epub 2009 May 4.

PMID:
19487055
20.

Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives.

Fragogeorgi EA, Zikos C, Gourni E, Bouziotis P, Paravatou-Petsotas M, Loudos G, Mitsokapas N, Xanthopoulos S, Mavri-Vavayanni M, Livaniou E, Varvarigou AD, Archimandritis SC.

Bioconjug Chem. 2009 May 20;20(5):856-67. doi: 10.1021/bc800475k.

PMID:
19344122

Supplemental Content

Loading ...
Support Center